July 3, 2025
Quebec Implements Public Reimbursement of Pluvicto® – A Defining Milestone for Radioligand Therapy in Canada
June 18, 2025
Health Canada Approves Novartis’ KISQALI® for HR+/HER2- Early Breast Cancer Patients at High Risk of Recurrence
April 14, 2025
Fabhalta® (Iptacopan Capsules), First Oral Treatment for Adult Patients with PNH, Now Available in Canada
No current content.